《药品不良反应信息通报》的回顾及存在问题  

Review on Chinese Adverse Drug Reaction Information Bulletin and Its Problems

作　　者：田春华[1] 夏东胜[1] 刘翠丽[1] 高建超[1] 

机构地区：[1]国家食品药品监督管理局药品评价中心,北京100045

出　　处：《中国药物警戒》2015年第9期531-533,537,共4页Chinese Journal of Pharmacovigilance

摘　　要：《药品不良反应信息通报》是我国最早建立的风险控制措施之一。2001～2014年共发布65期，对推动我国药品不良反应监测工作、保障公众用药安全发挥了积极的作用。本文对《药品不良反应信息通报》进行了全面回顾，并剖析了目前存在的问题，以期医药学专业人员更了解这项工作，推动药品不良反应监测工作发展。Chinese Adverse Drug Reaction Information Bulletin is one of the earliest risk control measures established in our country. From 2001 to 2014, a total of 65 issues were released which has played a positive role in promoting China＇s adverse drug reaction monitoring and protecting public safety. In this paper, the comprehensive review and analysis of the existing problems were conducted about Chinese Adverse Drug Reaction Information Bulletin, in order to make medical professionals learn more about the work and promote the development of adverse drug reaction monitoring.

关 键 词：药品不良反应信息通报 回顾 问题 

分 类 号：R994.11[医药卫生—毒理学]